Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 286(1): 123-30, 2011 Jan 07.
Article in English | MEDLINE | ID: mdl-21047788

ABSTRACT

A wide variety of nanomaterials are currently being developed for use in the detection and treatment of human diseases. However, there is no systematic way to measure and predict the action of such materials in biological contexts. Lipid-encapsulated nanoparticles (NPs) are a class of nanomaterials that includes the liposomes, the most widely used and clinically proven type of NPs. Liposomes can, however, activate the complement system, an important branch of innate immunity, resulting in undesirable consequences. Here, we describe the complement response to lipid-encapsulated NPs that are functionalized on the surface with various lipid-anchored gadolinium chelates. We developed a quantitative approach to examine the interaction of NPs with the complement system using in vitro assays and correlating these results with those obtained in an in vivo mouse model. Our results indicate that surface functionalization of NPs with certain chemical structures elicits swift complement activation that is initiated by a natural IgM antibody and propagated via the classical pathway. The intensity of the response is dependent on the chemical structures of the lipid-anchored chelates and not zeta potential effects alone. Moreover, the extent of complement activation may be tempered by complement inhibiting regulatory proteins that bind to the surface of NPs. These findings represent a step forward in the understanding of the interactions between nanomaterials and the host innate immune response and provide the basis for a systematic structure-activity relationship study to establish guidelines that are critical to the future development of biocompatible nanotherapeutics.


Subject(s)
Antibodies/immunology , Complement System Proteins/immunology , Nanocapsules/chemistry , Phospholipids , Animals , Drug Design , Gadolinium/chemistry , Humans , Immunoglobulin M/immunology , Mice , Nanocapsules/adverse effects , Surface Properties
2.
J Comb Chem ; 6(2): 239-54, 2004.
Article in English | MEDLINE | ID: mdl-15002973

ABSTRACT

This article describes the solid-phase combinatorial methods developed for the synthesis of polyhydroxamate-based siderophores. This strategy was applied to generate several libraries of structural DFO (1a) analogues that include DFO variants, non-amide analogues, C-terminal modified analogues, reverse-amide analogues, and hybrid analogues. To assess the relative iron-binding affinities of these compounds, a high-throughput spectrophotometric screening method based on competition with 8-hydroxyquinoline-5-sulfonic acid was developed. Some of the promising candidates containing various terminal functional groups were identified and prepared on large scale to enable future studies in animal models for iron-overload diseases.


Subject(s)
Deferoxamine/analogs & derivatives , Deferoxamine/chemistry , Hydroxamic Acids/chemistry , Iron Chelating Agents/chemical synthesis , Oxyquinoline/analogs & derivatives , Alkylation , Chromatography, High Pressure Liquid , Ferric Compounds/chemistry , Models, Chemical , Oxyquinoline/chemistry
3.
Bioorg Med Chem Lett ; 13(15): 2553-6, 2003 Aug 04.
Article in English | MEDLINE | ID: mdl-12852964

ABSTRACT

A solid-phase approach for the total synthesis of methyl carboxymycobactins 1a-d, with an on-resin cyclization leading to azopine 5 as the key step, was developed. The iron-affinity of these compounds was assessed by a competitive sulfoxine-binding assay, and antimycobacterial activity was tested against the growth of Mycobacterium avium.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , Mycobacterium avium Complex/drug effects , Oxazoles/chemical synthesis , Chromatography, High Pressure Liquid , Cyclization , Indicators and Reagents , Iron/chemistry , Iron Chelating Agents/pharmacology , Microbial Sensitivity Tests , Mycobacterium avium Complex/growth & development , Oxazoles/pharmacology , Spectrometry, Mass, Electrospray Ionization , Spectrophotometry, Ultraviolet
4.
J Org Chem ; 61(21): 7585-7592, 1996 Oct 18.
Article in English | MEDLINE | ID: mdl-11667692

ABSTRACT

4,13-Bis(benzotriazolylmethyl)-4,13-diaza-1,7,10,16-tetraoxacyclooctadecane (6) was synthesized as a versatile intermediate in the preparation of bis(lariats) of diaza-18-crown-6. N,N'-Bis(umbelliferon-8-ylmethyl) derivative 8, bis(lariats) with terminal unsaturated groups (11c,e), ester functionalities (11d), N,N'-di-beta-aralkyl derivatives (11a,b), and gamma-oxy-substituted (13, 14) and gamma-amino-substituted (17-19) propylene-side-armed derivatives were thus prepared in moderate to excellent yields. The X-ray structure of bis(lariat) 6 and stability constants for several of the complexes of bis(lariats), derivatives of 6, with metal cations are discussed.

5.
J Org Chem ; 61(21): 7578-7584, 1996 Oct 18.
Article in English | MEDLINE | ID: mdl-11667691

ABSTRACT

A series of new 15- and 18-membered N-pivot lariat aza-crown ethers having a propylene linkage in the side arm was prepared starting from functionalized diethanolamines and functionalized lariat aza-crown ethers containing the easily modified benzotriazole moiety. Addition reactions of such derivatives to electron-rich vinyl ethers or vinylamides followed by displacement of the benzotriazolyl group in the addition products by hydrogen (by reduction with LiAlH(4)) gives a variety of N-(3-oxo-3-substituted)- and N-(3-aza-3-substituted)propylene side-armed derivatives of aza-crown ethers. Stability constants for the complexes of several synthesized lariats with metal cations are discussed.

SELECTION OF CITATIONS
SEARCH DETAIL
...